Zhao Wang

FDA investigator · also recorded as Qn Err Zhao Wang, Rage Zhao Wang

Appears on 5 documents from 2017 to 2021, most often at sites in India. Most often cites production record review (21 CFR 211.192).

5
Documents on file
2.8
Observations per 483
2017
First seen
2021
Most recent

What they cite most

From 14 observations

Activity by year

2017: 1, 2018: 1, 2019: 1, 2021: 2

Where

India 1 · Maryland 1 · North Carolina 1 · South Carolina 1 · Virginia 1

Is Zhao Wang coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Biogen MA Inc.Jun 16, 2021 · Morrisville, North Carolina
483 AstraZeneca Pharmaceuticals LPMar 19, 2021 · Frederick, Maryland
483 Torrent Pharmaceuticals Limited Ahmedabad Mehsana Highway, Taluka-KadiApr 16, 2019 · Indrad, India
483 Granules Pharmaceuticals Inc.Oct 26, 2018 · Chantilly, Virginia
483 Alcami Carolinas CorporationDec 15, 2017 · Charleston, South Carolina

About this profile

What does Zhao Wang inspect?

Zhao Wang appears on 5 documents on file covering 5 sites, most often in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.22 and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Zhao Wang is dated Jun 16, 2021.

FDA Investigator Zhao Wang: 483s & Inspections · FDA Intel